IFNA17 and infection: Hyperglycemia itself as well as chronically impaired glucose metabolism in the course of diabetes trigger numerous metabolic signaling pathways leading to chronic inflammatory disease and impaired immune response to infection [17], which include the uncontrolled secretion of INF-α, other pro-inflammatory cytokines, and chemokines [18].